295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
Pneumonia increase likely caused by multiple viruses and bacteria More patients with pneumonia visited their GP from August 2023 on than in previous years. The rise in cases of pneumonia among children, adolescents and young adults aged 5–25 years is particularly notable.
Respiratory infections widespread, even more important to follow recommendations The number of people in the Netherlands with respiratory symptoms continues to increase. Besides COVID-19 and rhinovirus, the number of people who have flu is also increasing. We are also seeing more and more people with pneumonia. Some of these cases are caused by the bacteria Mycoplasma pneumoniae.
Respiratory infections now in season More and more people are coughing and sneezing, although it is not an epidemic at this point. The season in which respiratory infections circulate in the Netherlands has now started. There are various viruses that can cause respiratory infections.
MEBI: 193 reports of suspected side effects of implants in 2022 In 2022, 193 individuals reported suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI). Most reports received concerned breast implants, copper IUDs and wrinkle fillers. This is highlighted in MEBI’s annual report.
Dutch people eat more healthy foods: more plant products, less red and processed meat Dutch people are eating and drinking more healthily. We know this because of RIVM’s new Dutch National Food Consumption Survey (Voedselconsumptiepeiling, VCP). Dutch people are eating more plant products, like fruit and vegetables, unsalted nuts and legumes.
Higher alert level for Ebola There is an Ebola outbreak in several regions of Uganda that are also frequented by tourists. RIVM therefore asks medical professionals to be alert to symptoms that could indicate Ebola among people who have travelled to Uganda, and to request diagnostics to rule out or confirm Ebola.
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Antibiotic use and antimicrobial resistance remain stable Antibiotic resistance in the Netherlands remained stable in 2021 compared with the five previous years. This is evident from the 2022 annual NethMap/MARAN report.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.